Sort
15,842 grants matching “pancreatic cancer”
Pharmacological Ascorbate as a Radiosensitizer in Pancreatic Cancer
$347,986Joseph J Cullen · University Of Iowa · R01 · FY2016 · CA
Wnt/?-catenin Signaling in Pancreatic Oncogenesis
$347,918Anirban Maitra · University Of Tx Md Anderson Can Ctr · R01 · FY2023 · CA
Preclinical platform for theranostic nanoparticles in pancreatic cancer
$347,838Nancy J Halas · Rice University · U01 · FY2011 · CA
NRF2-dependent redox signaling in pancreatic cancer
$347,716Christine Iok In Chio · Columbia University Health Sciences · R01 · FY2024 · CA
Development of Targeted Nanotechnology Platform for Pancreatic Cancer
$347,700Subhash C. Chauhan · University Of Tennessee Health Sci Ctr · R01 · FY2016 · CA
Development of Targeted Nanotechnology Platform for Pancreatic Cancer
$347,700Subhash C. Chauhan · University Of Tennessee Health Sci Ctr · R01 · FY2018 · CA
Development of Targeted Nanotechnology Platform for Pancreatic Cancer
$347,700Subhash C. Chauhan · University Of Tennessee Health Sci Ctr · R01 · FY2017 · CA
Targeted Nanotherapy for Pancreatic Cancer
$347,700Subhash C. Chauhan · University Of Tennessee Health Sci Ctr · R01 · FY2016 · CA
Targeted Nanotherapy for Pancreatic Cancer
$347,700Subhash C. Chauhan · University Of Tennessee Health Sci Ctr · R01 · FY2017 · CA
Systemic Therapy with Infectivity-Selective Oncolytic Adenovirus for PDAC
$347,700Masato Yamamoto · University Of Minnesota · R01 · FY2016 · CA
Targeted Nanotherapy for Pancreatic Cancer
$347,700Subhash C. Chauhan · University Of Tennessee Health Sci Ctr · R01 · FY2018 · CA
Development, cellular plasticity and homeostasis of the exocrine pancreas
$347,625Beatriz Sosa-Pineda · Northwestern University At Chicago · R01 · FY2018 · DK
Type I Interferon Pathway in Pancreatic Adenocarcinoma
$347,592Serge Y Fuchs · University Of Pennsylvania · R01 · FY2024 · CA
Human Ribonuclease as a Cytotoxin
$347,477Ronald T Raines · Massachusetts Institute Of Technology · R01 · FY2023 · CA
Human Ribonuclease as a Cytotoxin
$347,477Ronald T Raines · Massachusetts Institute Of Technology · R01 · FY2020 · CA
Human Ribonuclease as a Cytotoxin
$347,477Ronald T Raines · Massachusetts Institute Of Technology · R01 · FY2021 · CA
Mechanisms of pancreatic cancer initiation and progression from normal human pancreatic tissue
$347,471Pei Wang · University Of Texas Hlth Science Center · R01 · FY2023 · CA
Enhancing engineered T cell therapeutic efficacy for the treatment of pancreatic ductal adenocarcinoma
$347,471Ingunn Margarete Stromnes · University Of Minnesota · R01 · FY2023 · CA
Enhancing engineered T cell therapeutic efficacy for the treatment of pancreatic ductal adenocarcinoma
$347,471Ingunn Margarete Stromnes · University Of Minnesota · R01 · FY2022 · CA
Dysregulation of TGF Beta Action Pancreatic Cancer
$347,417Murray Korc · Dartmouth College · R01 · FY2006 · CA
The Impact of Macrophage Origin on the Pathogenesis and Treatment Resistance of Pancreatic Cancer
$347,289David G Denardo · Washington University · R01 · FY2023 · CA
The Impact of Macrophage Origin on the Pathogenesis and Treatment Resistance of Pancreatic Cancer
$347,286David G Denardo · Washington University · R01 · FY2022 · CA
PKD1 signaling in the initiation of pancreatic cancer
$347,253Peter Storz · Mayo Clinic Jacksonville · R01 · FY2019 · CA
ZIP4 is a Novel Molecular Target in Human Pancreatic Cancer
$347,191Min Li · University Of Oklahoma Hlth Sciences Ctr · R01 · FY2016 · CA
Selective Sensitization of Pancreatic Cancer to Therapy by Chk1 and PARP1 Inhibit
$347,032Meredith A Morgan · University Of Michigan At Ann Arbor · R01 · FY2015 · CA